{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:26:23Z","timestamp":1792074383085,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>For breast cancer patients undergoing neoadjuvant chemotherapy (NAC), pathologic complete response (pCR; no invasive or in situ) cannot be assessed non-invasively so all patients undergo surgery. The aim of our study was to develop and validate a radiomics classifier that classifies breast cancer pCR post-NAC on MRI prior to surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included women treated with NAC for breast cancer from 2014 to 2016 with (1) pre- and post-NAC breast MRI and (2) post-NAC surgical pathology report assessing response. Automated radiomics analysis of pre- and post-NAC breast MRI involved image segmentation, radiomics feature extraction, feature pre-filtering, and classifier building through recursive feature elimination random forest (RFE-RF) machine learning. The RFE-RF classifier was trained with nested five-fold cross-validation using (a) radiomics only (model 1) and (b) radiomics and molecular subtype (model 2). Class imbalance was addressed using the synthetic minority oversampling technique.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two hundred seventy-three women with 278 invasive breast cancers were included; the training set consisted of 222 cancers (61 pCR, 161 no-pCR; mean age 51.8\u2009years, SD 11.8), and the independent test set consisted of 56 cancers (13 pCR, 43 no-pCR; mean age 51.3\u2009years, SD 11.8). There was no significant difference in pCR or molecular subtype between the training and test sets. Model 1 achieved a cross-validation AUROC of 0.72 (95% CI 0.64, 0.79) and a similarly accurate (<jats:italic>P<\/jats:italic>\u2009=\u20090.1) AUROC of 0.83 (95% CI 0.71, 0.94) in both the training and test sets. Model 2 achieved a cross-validation AUROC of 0.80 (95% CI 0.72, 0.87) and a similar (<jats:italic>P<\/jats:italic>\u2009=\u20090.9) AUROC of 0.78 (95% CI 0.62, 0.94) in both the training and test sets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study validated a radiomics classifier combining radiomics with molecular subtypes that accurately classifies pCR on MRI post-NAC.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13058-020-01291-w","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T11:04:17Z","timestamp":1590663857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-7012","authenticated-orcid":false,"given":"Elizabeth J.","family":"Sutton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc A.","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany Z.","family":"Dashevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Sadinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny F.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edi","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"El-Tamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Sacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Deasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"issue":"5","key":"1291_CR1","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1245\/s10434-015-4403-9","volume":"22","author":"V Dialani","year":"2015","unstructured":"Dialani V, Chadashvili T, Slanetz PJ. Role of imaging in neoadjuvant therapy for breast cancer. Ann Surg Oncol. 2015;22(5):1416\u201324.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1291_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1245\/s10434-015-4406-6","volume":"22","author":"EP Mamounas","year":"2015","unstructured":"Mamounas EP. Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer. Ann Surg Oncol. 2015;22(5):1425\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1291_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1148\/radiol.14131332","volume":"272","author":"N Cho","year":"2014","unstructured":"Cho N, Im SA, Park IA, Lee KH, Li M, Han W, et al. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging. Radiology. 2014;272(2):385\u201396.","journal-title":"Radiology."},{"issue":"3","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1148\/radiol.2333031484","volume":"233","author":"WA Berg","year":"2004","unstructured":"Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830\u201349.","journal-title":"Radiology."},{"issue":"3","key":"1291_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2214\/ajr.184.3.01840868","volume":"184","author":"E Yeh","year":"2005","unstructured":"Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol. 2005;184(3):868\u201377.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"1291_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","volume":"17","author":"YL Gu","year":"2017","unstructured":"Gu YL, Pan SM, Ren J, Yang ZX, Jiang GQ. Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis. Clin Breast Cancer. 2017;17(4):245\u201355.","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"1291_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.6004\/jnccn.2017.0158","volume":"15","author":"L Spring","year":"2017","unstructured":"Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, et al. Pathologic complete response after neoadjuvant chemotherapy and long-term outcomes among young women with breast cancer. J Natl Compr Canc Netw. 2017;15(10):1216\u201323.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1291_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12094-019-02109-8","volume":"22","author":"Qianqian Xiong","year":"2019","unstructured":"Xiong Q, Zhou X, Liu Z, Lei C, Yang C, Yang M, et al. Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy. Clin Transl Oncol. 2020;22(1):50\u20139.","journal-title":"Clinical and Translational Oncology"},{"issue":"4","key":"1291_CR9","doi-asserted-by":"publisher","first-page":"e192561","DOI":"10.1001\/jamanetworkopen.2019.2561","volume":"2","author":"N Braman","year":"2019","unstructured":"Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, et al. Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)-positive breast cancer. JAMA Netw Open. 2019;2(4):e192561.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1291_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.tranon.2015.03.005","volume":"8","author":"A Ashraf","year":"2015","unstructured":"Ashraf A, Gaonkar B, Mies C, DeMichele A, Rosen M, Davatzikos C, et al. Breast DCE-MRI kinetic heterogeneity tumor markers: preliminary associations with neoadjuvant chemotherapy response. Transl Oncol. 2015;8(3):154\u201362.","journal-title":"Transl Oncol"},{"issue":"2","key":"1291_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3322\/caac.21552","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127\u201357.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1291_CR12","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1038\/s41598-018-22980-9","volume":"8","author":"H Veeraraghavan","year":"2018","unstructured":"Veeraraghavan H, Dashevsky BZ, Onishi N, Sadinski M, Morris E, Deasy JO, et al. Appearance constrained semi-automatic segmentation from DCE-MRI is reproducible and feasible for breast cancer radiomics: a feasibility study. Sci Rep. 2018;8(1):4838.","journal-title":"Sci Rep"},{"issue":"6","key":"1291_CR13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29(6):1310\u201320.","journal-title":"IEEE Trans Med Imaging"},{"issue":"16","key":"1291_CR14","doi-asserted-by":"publisher","first-page":"165011","DOI":"10.1088\/1361-6560\/ab2f44","volume":"64","author":"H Um","year":"2019","unstructured":"Um H, Tixier F, Bermudez D, Deasy JO, Young RJ, Veeraraghavan H. Impact of image preprocessing on the scanner dependence of multi-parametric MRI radiomic features and covariate shift in multi-institutional glioblastoma datasets. Phys Med Biol. 2019;64(16):165011.","journal-title":"Phys Med Biol"},{"issue":"6","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","volume":"SMC-3","author":"RM Haralick","year":"1973","unstructured":"Haralick RM, Shanmugam K, Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybernetics. 1973;SMC-3(6):610\u201321.","journal-title":"IEEE Trans Syst Man Cybernetics"},{"issue":"7","key":"1291_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1364\/JOSAA.2.001160","volume":"2","author":"JG Daugman","year":"1985","unstructured":"Daugman JG. Uncertainty relation for resolution in space, spatial frequency, and orientation optimized by two-dimensional visual cortical filters. J Opt Soc Am A Opt Image Sci. 1985;2(7):1160\u20139.","journal-title":"J Opt Soc Am A Opt Image Sci"},{"issue":"3","key":"1291_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0734-189X(84)90197-X","volume":"25","author":"RW Conners","year":"1984","unstructured":"Conners RW, Trivedi MM, Harlow CA. Segmentation of a high-resolution urban scene using texture operators. Compute Vis Graph Image Process. 1984;25(3):273\u2013310.","journal-title":"Compute Vis Graph Image Process"},{"issue":"46","key":"1291_CR18","doi-asserted-by":"publisher","first-page":"E6265","DOI":"10.1073\/pnas.1505935112","volume":"112","author":"D Fehr","year":"2015","unstructured":"Fehr D, Veeraraghavan H, Wibmer A, Gondo T, Matsumoto K, Vargas HA, et al. Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc Natl Acad Sci U S A. 2015;112(46):E6265\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1291_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1148\/radiol.2018172300","volume":"287","author":"N Horvat","year":"2018","unstructured":"Horvat N, Veeraraghavan H, Khan M, Blazic I, Zheng J, Capanu M, et al. MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology. 2018;287(3):833\u201343.","journal-title":"Radiology."},{"issue":"8","key":"1291_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","volume":"27","author":"Hanchuan Peng","year":"2005","unstructured":"Peng H, Long F, Ding C. Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy. IEEE Transactions on pattern analysis and machine intelligence. 2005;27(8):1226\u201338.","journal-title":"IEEE Transactions on Pattern Analysis and Machine Intelligence"},{"issue":"1","key":"1291_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1.","journal-title":"J Stat Softw"},{"issue":"Suppl 1","key":"1291_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12863-018-0633-8","volume":"19","author":"BF Darst","year":"2018","unstructured":"Darst BF, Malecki KC, Engelman CD. Using recursive feature elimination in random forest to account for correlated variables in high dimensional data. BMC Genet. 2018;19(Suppl 1):65.","journal-title":"BMC Genet"},{"issue":"1","key":"1291_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1471-2105-9-319","volume":"9","author":"Alexander Statnikov","year":"2008","unstructured":"Statnikov A, Wang L, Aliferis CF. A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification. BMC Bioinforma. 2008;9(1):319.","journal-title":"BMC Bioinformatics"},{"key":"1291_CR24","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2016","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna. https:\/\/www.R-project.org\/: R Foundation for Statistical Computing; 2016."},{"issue":"8","key":"1291_CR25","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1002\/mp.13046","volume":"45","author":"Aditya P. Apte","year":"2018","unstructured":"Apte AP, Iyer A, Crispin-Ortuzar M, Pandya R, van Dijk LV, Spezi E, et al. Technical note: extension of CERR for computational radiomics: a comprehensive MATLAB platform for reproducible radiomics research. Med Phys. 2018.\u00a0https:\/\/doi.org\/10.1002\/mp.13046.\u00a0.","journal-title":"Medical Physics"},{"issue":"1","key":"1291_CR26","first-page":"5","volume":"45","author":"LJML Breiman","year":"2001","unstructured":"Breiman LJML. Random Forests. 2001;45(1):5\u201332.","journal-title":"Random Forests"},{"issue":"1","key":"1291_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207\u201314.","journal-title":"Cancer."},{"issue":"2","key":"1291_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Canc (Oxford). 2009;45(2):228\u201347.","journal-title":"Eur J Canc (Oxford)"},{"issue":"3","key":"1291_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1245\/s10434-015-4918-0","volume":"23","author":"B Schaefgen","year":"2016","unstructured":"Schaefgen B, Mati M, Sinn HP, Golatta M, Stieber A, Rauch G, et al. Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response? Ann Surg Oncol. 2016;23(3):789\u201395.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1291_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jnci\/djs528","volume":"105","author":"ML Marinovich","year":"2013","unstructured":"Marinovich ML, Houssami N, Macaskill P, Sardanelli F, Irwig L, Mamounas EP, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst. 2013;105(5):321\u201333.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1291_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/bjc.2015.381","volume":"113","author":"Joerg Heil","year":"2015","unstructured":"Heil J, Kummel S, Schaefgen B, Paepke S, Thomssen C, Rauch G, et al. Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br J Cancer. 2015;113(11):1565\u201370.","journal-title":"British Journal of Cancer"},{"issue":"7","key":"1291_CR32","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1245\/s10434-018-6481-y","volume":"25","author":"Gaiane M. Rauch","year":"2018","unstructured":"Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, et al. Biopsy feasibility trial for breast cancer pathologic complete response detection after neoadjuvant chemotherapy: imaging assessment and correlation endpoints. Ann Surg Oncol. 2018;25(7):1953\u201360.","journal-title":"Annals of Surgical Oncology"},{"issue":"5","key":"1291_CR33","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/SLA.0000000000002313","volume":"267","author":"Henry M. Kuerer","year":"2018","unstructured":"Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, et al. A Clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg Oncol. 2018;267(5):946\u201351.","journal-title":"Annals of Surgery"},{"issue":"10","key":"1291_CR34","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1245\/s10434-017-5926-z","volume":"24","author":"Henry M. Kuerer","year":"2017","unstructured":"Kuerer HM, Vrancken Peeters M, Rea DW, Basik M, De Los Santos J, Heil J. Nonoperative management for invasive breast cancer after neoadjuvant systemic therapy: conceptual basis and fundamental international feasibility clinical trials. Ann Surg. 2017;24(10):2855\u201362.","journal-title":"Annals of Surgical Oncology"},{"key":"1291_CR35","doi-asserted-by":"crossref","unstructured":"van la Parra RF, Kuerer HM. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials. Breast Cancer Res. 2016;18(1):28.","DOI":"10.1186\/s13058-016-0684-6"},{"key":"1291_CR36","doi-asserted-by":"crossref","unstructured":"Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast cancer research: BCR. 2017;19(1):57.","DOI":"10.1186\/s13058-017-0846-1"},{"issue":"2","key":"1291_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1148\/radiol.2017170143","volume":"286","author":"Foucauld Chamming\u2019s","year":"2018","unstructured":"Chamming's F, Ueno Y, Ferre R, Kao E, Jannot AS, Chong J, et al. Features from computerized texture analysis of breast cancers at pretreatment mr imaging are associated with response to neoadjuvant chemotherapy. Radiology. 2018;286(2):412\u201320.","journal-title":"Radiology"},{"key":"1291_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejrad.2017.06.019","volume":"94","author":"Ming Fan","year":"2017","unstructured":"Fan M, Wu G, Cheng H, Zhang J, Shao G, Li L. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients. Eur J Radiol. 2017;94:140\u20137.","journal-title":"European Journal of Radiology"},{"issue":"1","key":"1291_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1148\/radiol.2018172462","volume":"288","author":"Jia Wu","year":"2018","unstructured":"Wu J, Cao G, Sun X, Lee J, Rubin DL, Napel S, et al. Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy. Radiology. 2018;288(1):26\u201335.","journal-title":"Radiology"},{"issue":"2","key":"1291_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10549-018-4990-9","volume":"173","author":"Elizabeth Hope Cain","year":"2018","unstructured":"Cain EH, Saha A, Harowicz MR, Marks JR, Marcom PK, Mazurowski MA. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set. Breast Cancer Res Treat. 2018;173(2):455\u201363.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"1291_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/RLI.0000000000000518","volume":"54","author":"Amirhessam Tahmassebi","year":"2019","unstructured":"Tahmassebi A, Wengert GJ, Helbich TH, Bago-Horvath Z, Alaei S, Bartsch R, et al. Impact of machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy and survival outcomes in breast cancer patients. Investig Radiol. 2019;54(2):110\u201317.","journal-title":"Investigative Radiology"},{"key":"1291_CR42","doi-asserted-by":"crossref","unstructured":"Thibault G, Tudorica A, Afzal A, Chui SY, Naik A, Troxell ML, et al. DCE-MRI texture features for early prediction of breast cancer therapy response. Tomography. 2017;3(1):23\u201332.","DOI":"10.18383\/j.tom.2016.00241"},{"key":"1291_CR43","doi-asserted-by":"crossref","unstructured":"Drukker K, Li H, Antropova N, Edwards A, Papaioannou J, Giger ML. Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival \"early on\" in neoadjuvant treatment of breast cancer. Cancer imaging. 2018;18(1):12.","DOI":"10.1186\/s40644-018-0145-9"},{"issue":"15","key":"1291_CR44","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1158\/1078-0432.CCR-16-3115","volume":"23","author":"CKY Ng","year":"2017","unstructured":"Ng CKY, Bidard FC, Piscuoglio S, Geyer FC, Lim RS, de Bruijn I, et al. Genetic heterogeneity in therapy-naive synchronous primary breast cancers and their metastases. Clin Canc Res. 2017;23(15):4402\u201315.","journal-title":"Clin Canc Res"},{"issue":"6","key":"1291_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12672-014-0196-8","volume":"5","author":"AM Sieuwerts","year":"2014","unstructured":"Sieuwerts AM, Willis S, Burns MB, Look MP, Meijer-Van Gelder ME, Schlicker A, et al. Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers. Hormones Cancer. 2014;5(6):405\u201313.","journal-title":"Hormones Cancer"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-020-01291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-020-01291-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-020-01291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T16:24:33Z","timestamp":1696177473000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-020-01291-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1186\/s13058-020-01291-w","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"22 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This single-institution retrospective study was compliant with Health Insurance Portability and Accountability Act guidelines and approved by the Memorial Sloan Kettering Cancer Center Institutional Review Board with a waiver of written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Katja Pinker received payment for activities not related to the present article including lectures including service on speakers bureaus and for travel\/accommodations\/meeting expenses unrelated to activities listed from the European Society of Breast Imaging (MRI educational course, annual scientific meeting) and the IDKD 2019 (educational course). Elizabeth A Morris received a grant from GRAIL Inc. for research not related to the present article. The remaining authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}